Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase

This publication has 13 references indexed in Scilit:

• Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
  European Heart Journal, 1996
• Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency: The GUSTO Enzyme Substudy
  European Heart Journal, 1996
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy
  European Heart Journal, 1993
• Acute Phase Reaction, Infarct Size and In-Hospital Morbidity in Myocardial Infarction Patients Treated With Streptokinase or Recombinant Tissue Type Plasminogen Activator
  Annals of Medicine, 1991
• Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction.
  Heart, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.
  Heart, 1982
• C-REACTIVE PROTEIN FIFTY YEARS ON
  The Lancet, 1981